Immune and Neurohormonal Pathways in Chronic Heart Failure
Key result
Anticytokine therapy could be a successful approach for advanced heart failure, which is considered a state of chronic inflammation driven by interactions among immune and neurohormonal pathways.
Population
Patients with chronic heart failure
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Immune interactions in heart failure remain understudied; leaves open whether targeting them extends outcomes beyond neurohormonal therapies.
Structured PICO
P
Population
Patients with chronic heart failure
I
Intervention
Anticytokine therapy (discussed conceptually)
Advanced heart failure is characterized by chronic inflammation, suggesting that monitoring immune and neurohormonal status and potentially targeting cytokines could be important future strategies.
Limitations
- Anticytokine therapies carry risks and are very expensive, which may limit their application to certain subgroups of patients.
Cite This Study
Sharma et al. (2002) conducted a review in Chronic heart failure. Anticytokine therapy was evaluated. Anticytokine therapy could be a successful approach for advanced heart failure, which is considered a state of chronic inflammation driven by interactions among immune and neurohormonal pathways.